Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE)

在老年人普伐他汀抗动脉粥样硬化试验 (PATE) 中，糖尿病患者接受普伐他汀降胆固醇治疗会增加心血管疾病的风险。